Literature DB >> 21606253

Complications of CT-guided percutaneous needle biopsy of the chest: prevention and management.

Carol C Wu1, Michael M Maher, Jo-Anne O Shepard.   

Abstract

OBJECTIVE: The objective of this article is to describe potential complications of percutaneous needle biopsy of the chest, discuss the risk factors associated with the development of complications, and explain how to prevent complications and manage complications when they occur.
CONCLUSION: Pneumothorax and pulmonary hemorrhage are the most common complications of percutaneous needle biopsy of the chest, whereas air embolism and tumor seeding are extremely rare. Attention to biopsy planning and technique and postprocedural care help to prevent or minimize most potential complications.

Entities:  

Mesh:

Year:  2011        PMID: 21606253     DOI: 10.2214/AJR.10.4659

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  106 in total

1.  Atrial fibrillation and pneumothorax after transthoracic needle lung biopsy.

Authors:  Alexander Liu; Iain Southern; Edward Nicol
Journal:  BMJ Case Rep       Date:  2012-01-18

2.  Where are we on (preventing) pneumothorax after (cone-beam) computed tomography-guided lung biopsy?

Authors:  Myrthe M Vestering; Sicco J Braak
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

3.  Is the rapid needle-out patient-rollover approach after CT-guided lung biopsy really effective for pneumothorax prevention?

Authors:  Zafar Neyaz; Namita Mohindra
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

Review 4.  Trans-thoracic biopsy of lung lesions: FNAB or CNB? Our experience and review of the literature.

Authors:  Emanuela Capalbo; Michela Peli; Maria Lovisatti; Maria Cosentino; Paola Mariani; Eisabetta Berti; Maurizio Cariati
Journal:  Radiol Med       Date:  2013-12-03       Impact factor: 3.469

5.  A novel technique for CT-guided transthoracic biopsy of lung lesions: improved biopsy accuracy and safety.

Authors:  Daniel Yaffe; Matthew Koslow; Hassan Haskiya; David Shitrit
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

6.  Safety and diagnostic performance of image-guided lung biopsy in the targeted therapy era.

Authors:  Marco Busso; Diego Sardo; Irene Garetto; Luisella Righi; Giulia Libero; Tiziana Vavalà; Francesco Ardissone; Silvia Novello; Mauro Papotti; Andrea Veltri
Journal:  Radiol Med       Date:  2015-05-01       Impact factor: 3.469

7.  Interstitial Fluid Pressure Correlates Clinicopathological Factors of Lung Cancer.

Authors:  Takeshi Mori; Takamasa Koga; Hidekatsu Shibata; Koei Ikeda; Kenji Shiraishi; Makoto Suzuki; Ken-ichi Iyama
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-01-26       Impact factor: 1.520

8.  Safety and effectiveness of stereotactic body radiotherapy for a clinically diagnosed primary stage I lung cancer without pathological confirmation.

Authors:  Katsuyuki Sakanaka; Yukinori Matsuo; Yasushi Nagata; Sayo Maki; Keiko Shibuya; Yoshiki Norihisa; Masaru Narabayashi; Nami Ueki; Takashi Mizowaki; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2013-11-12       Impact factor: 3.402

9.  Tumor acquisition for biomarker research in lung cancer.

Authors:  Marvaretta Stevenson; Jared Christensen; Debra Shoemaker; Traci Foster; William T Barry; Betty C Tong; Momen Wahidi; Scott Shofer; Michael Datto; Geoffrey Ginsburg; Jeffrey Crawford; Thomas D'Amico; Neal Ready
Journal:  Cancer Invest       Date:  2014-05-09       Impact factor: 2.176

10.  Factors affecting the accuracy and safety of computed tomography-guided biopsy of intrapulmonary solitary nodules ≤30 mm in a retrospective study of 155 patients.

Authors:  Gang Zhao; Xiaobao Shi; Wei Sun; Hongyuan Liang; Xiaonan Mao; Feng Wen; Ming Shan; Xihai Wang; Zaiming Lu
Journal:  Exp Ther Med       Date:  2017-03-02       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.